Athira Pharma Inc
Change company Symbol lookup
Select an option...
ATHA Athira Pharma Inc
AMRC Ameresco Inc
ET Energy Transfer LP
AHCO Adapthealth Corp
LPSN LivePerson Inc
BGSF BGSF Inc
NEE Nextera Energy Inc
PSB-Y PS Business Parks Inc
ADBE Adobe Inc
APWL Advanced Powerline Technologies Inc
Go

Health Care : Pharmaceuticals |
Company profile

Athira Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing small molecules to restore neuronal health and stop neurodegeneration. The Company’s pipeline is built from its drug discovery platform, ATH platform and consists of a series of small molecules that are designed to target either the central nervous system (CNS), by crossing the blood brain barrier (BBB), or the peripheral nervous system. Its lead candidate, ATH-1017, is a subcutaneous administered, BBB-penetrating, small molecule hepatocyte growth factor/mesenchymal-epithelial transition factor (HGF/MET) activator for the treatment of neurodegenerative disorders, with an initial focus on Alzheimer’s disease (AD). The Company also has preclinical candidates for non-AD indications, including ATH-1018, which is being developed to address peripheral indications, and ATH-1019 / ATH-1020 compounds, which are being advanced to address neuropsychiatric indications.

Closing Price
$13.07
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
421,045
0

CLASS ACTION UPDATE for SLQT, EAR and APPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

5:42 am ET October 13, 2021 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / October 13, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

SLQT Shareholders Click Here: https://www.zlk.com/pslra-1/selectquote-inc-loss-submission-form?prid=20376&wire=1

EAR Shareholders Click Here: https://www.zlk.com/pslra-1/eargo-inc-loss-submission-form?prid=20376&wire=1

APPH Shareholders Click Here: https://www.zlk.com/pslra-1/appharvest-inc-loss-submission-form?prid=20376&wire=1

* ADDITIONAL INFORMATION BELOW *

Image: https://www.accesswire.com/users/newswire/images/667879/Rotating-Logo.jpg

Selectquote, Inc. (NYSE:SLQT)

SLQT Lawsuit on behalf of: investors who purchased May 20, 2020 - August 25, 2021

Lead Plaintiff Deadline : October 15, 2021

TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/selectquote-inc-loss-submission-form?prid=20376&wire=1

According to the filed complaint, during the class period, Selectquote, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) SelectQuote's 2019 cohort was underperforming; (2) as a result, the Company's financial results would be adversely impacted; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis

Eargo, Inc. (NASDAQ:EAR)

EAR Lawsuit on behalf of: investors who purchased October 16, 2020 - September 22, 2021

Lead Plaintiff Deadline : December 6, 2021

TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/eargo-inc-loss-submission-form?prid=20376&wire=1

According to the filed complaint, during the class period, Eargo, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Eargo had improperly sought reimbursements from certain third-party payors; (2) the foregoing was reasonably likely to lead to regulatory scrutiny; (3) as a result and because the reimbursements at issue involved the Company's largest third-party payor, Eargo's financial results would be adversely impacted; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

AppHarvest, Inc. (NASDAQ:APPH)

APPH Lawsuit on behalf of: investors who purchased May 17, 2021 - August 10, 2021

Lead Plaintiff Deadline : November 23, 2021

TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/appharvest-inc-loss-submission-form?prid=20376&wire=1

According to the filed complaint, during the class period, AppHarvest, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) AppHarvest lacked sufficient training for its recently expanded labor force; (2) as a result, the Company could not produce Grade No. 1 tomatoes consistently; (3) as a result, the Company's financial results would be adversely impacted; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

Eduard Korsinsky, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

SOURCE: Levi & Korsinsky, LLP

View source version on accesswire.com:

https://www.accesswire.com/667879/CLASS-ACTION-UPDATE-for-SLQT-EAR-and-APPH-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders

comtex tracking

COMTEX_395088754/2457/2021-10-13T05:42:53

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.